Apyx Medical Q2 Gaap EPS $(0.19) Beats $(0.20) Estimate, Sales $12.15M Beat $11.75M Estimate
Author: Benzinga Newsdesk | August 08, 2024 05:21pm
Apyx Medical (NASDAQ:
APYX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 72.73 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $12.15 million which beat the analyst consensus estimate of $11.75 million by 3.40 percent. This is a 10.47 percent decrease over sales of $13.57 million the same period last year.
Posted In: APYX